Skip to content

Investigating the Effect of Celery Capsules on the Quality of Sleep and Quality of Life of the Elderly

Investigating the Effectiveness of the Traditional Persian Medicine Product based on the Apium Graveolens on the Sleep Quality and Quality of Life of the Community-Dwelling Elderly

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240217061029N1
Enrollment
70
Registered
2024-03-04
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders in the Elderly.

Interventions

Intervention 1: Intervention Group: due to the Lack of a Similar Study to Investigate the Effectiveness of Celery Plant on Sleep Quality, in Order to Determine the Drug Dose, First 10 Patients (Elderl

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Desire to Participate in the Study and Give Informed Consent Age 60 Years and Older Low Quality of Sleep based on the Pittsburgh Sleep Quality Standard Questionnaire (Score 5 and above) Not Having Cognitive Impairment and Speech Impairment (Getting a Score of 25 or Higher on the MMSE Test) Not Having Diagnosed Mental Disorders that Interfere with Sleep, such as Restless Leg Syndrome, Obstructive Sleep Apnea, and Severe Depression and Anxiety Disorders, and are Treated with Relevant Drugs Not Having Dependence on any Narcotic Drugs, Sleeping Pills and Alcohol and Not Consuming These Items in the Last Month Not Having any History of Allergy to Celery and Similar Compounds Not Taking Drugs that Affect the Sleep-Wake Cycle and Anticoagulants Not Suffering from Physical Diseases that Affect the Sleep-Wake Cycle, such as Cancer, Liver and Kidney Disorders, Severe Anemia that Requires Treatment, and Coronary Heart Disorders. Not having Epilepsy, History of low Blood Pressure The Ability to Consume the Product Orally

Exclusion criteria

Exclusion criteria: Not Taking Medicine for 5 Consecutive Nights or 10 Alternating Nights Showing any Allergic Reaction to the Drug Reluctance to Cooperate Leaving the Study due to Reasons such as Death and Illness Unfortunate Events such as the Death of Relatives

Design outcomes

Primary

MeasureTime frame
The Sleep Quality Score of the Elderly based on the Pittsburgh Sleep Quality Standard Questionnaire. Timepoint: The Beginning of the Study (before the Start of the Intervention) and 4 Weeks after the Start of the Intervention. Method of measurement: Pittsburgh Sleep Quality Standard Questionnaire.

Secondary

MeasureTime frame
The Score of the Quality of Life of the Elderly based on the Standard Questionnaire of the Quality of Life of the Elderly Lipad. Timepoint: The Beginning of the Study (before the Start of the Intervention) and 4 Weeks after the Start of the Intervention. Method of measurement: Standard Questionnaire of the Quality of Life of the Elderly Lipad.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamta Ghasemi

Mazandaran University of Medical Sciences

hamta.ghasemi@mazums.ac.ir+98 11 3336 9274

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026